Streetbeat News

Products Services

CARR

Carrier Global announced that its subsidiary, Sensitech, will acquire Berlinger & Co. Monitoring Solutions to enhance its life sciences cold chain solutions.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 4:54 pm

MSFT

Microsoft has successfully addressed multiple vulnerabilities within its Azure Machine Learning Service, including server-side request forgeries and a path traversal vulnerability. The company is working to enhance defense-in-depth by collaborating with partner open-source software teams.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 4:53 pm

MSFT

Microsoft announced that it blocked a server-side request forgeries (SSRF) attack vector on May 9 by implementing strict verification of client inputs and HTTP redirects. The company is also evaluating all service-to-service network traffic and plans to apply stricter controls on intra-network communication.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 4:52 pm

GOOG

GOOGL

IBM

MCD

SOUN

McDonald's (NYSE:MCD) is ending its AI drive-thru test with IBM (NYSE:IBM) but remains committed to exploring AI solutions, potentially with new partners like Google (NASDAQ:GOOG, NASDAQ:GOOGL). The decision follows mixed results from the AI test, with McDonald's aiming to make a future decision on voice ordering solutions by the end of the year.

Portfolio Pulse from Chris Katje

June 17, 2024 | 4:40 pm

MRK

Merck & Co announced that the FDA has approved the use of Pembrolizumab in combination with chemotherapy for the treatment of primary advanced or recurrent endometrial carcinoma.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 4:32 pm

QCOM

TSM

Analyst Ming-Chi Kuo reports that Qualcomm may become the exclusive SoC supplier for the Samsung Galaxy S25, replacing Samsung's Exynos 2500 due to lower-than-expected yield rates in Samsung's 3nm process. This shift is expected to significantly benefit Qualcomm and its exclusive supplier, TSMC.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 4:20 pm

GILD

Gilead Sciences Inc's (NASDAQ:GILD) blood cancer drug Magrolimab, acquired through a $4.9 billion buyout of Forty Seven Inc, has shown higher deaths and side effects in halted trials. The drug failed to meet primary endpoints in Phase 3 trials, leading to a negative market reaction.

Portfolio Pulse from Vandana Singh

June 17, 2024 | 4:19 pm

NVNO

enVVeno Medical Corporation (NASDAQ:NVNO) announced that new interim data from its VenoValve U.S. pivotal trial will be presented at the VAM2024 Vascular Annual Meeting on June 21, 2024. The data focuses on the impact of VenoValve implantation on venous ulcer healing in patients with deep venous reflux.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 4:16 pm

LIF

Life360 has achieved a significant milestone by surpassing 2 million global paying subscriber circles for its app, demonstrating exceptional value for its members.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 4:16 pm

AAN

ALLG

AVTE

MBIO

OVID

WKHS

U.S. stocks traded mixed with the S&P 500 edging higher. Mustang Bio shares surged 240% on positive clinical trial data, Allego shares rose 127% on a tender offer, and Aaron’s Company shares increased 32% on an acquisition agreement. Aerovate Therapeutics, Workhorse Group, and Ovid Therapeutics saw significant declines.

Portfolio Pulse from Avi Kapoor

June 17, 2024 | 4:16 pm